IT8147518A0 - Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina - Google Patents

Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina

Info

Publication number
IT8147518A0
IT8147518A0 IT8147518A IT4751881A IT8147518A0 IT 8147518 A0 IT8147518 A0 IT 8147518A0 IT 8147518 A IT8147518 A IT 8147518A IT 4751881 A IT4751881 A IT 4751881A IT 8147518 A0 IT8147518 A0 IT 8147518A0
Authority
IT
Italy
Prior art keywords
treatment
pharmaceutical composition
composition including
carnitine deficiency
including gamma
Prior art date
Application number
IT8147518A
Other languages
English (en)
Other versions
IT1198434B (it
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of IT8147518A0 publication Critical patent/IT8147518A0/it
Priority to IT47518/81A priority Critical patent/IT1198434B/it
Priority to US06/332,562 priority patent/US4382092A/en
Priority to IL64632A priority patent/IL64632A0/xx
Priority to BE0/206948A priority patent/BE891639A/fr
Priority to AU79087/81A priority patent/AU548787B2/en
Priority to IE3099/81A priority patent/IE52404B1/en
Priority to DE19823200016 priority patent/DE3200016A1/de
Priority to SE8200007A priority patent/SE453569B/sv
Priority to GB8200054A priority patent/GB2091101B/en
Priority to GR66937A priority patent/GR75132B/el
Priority to CH31/82A priority patent/CH649218A5/it
Priority to JP57000842A priority patent/JPS57136516A/ja
Priority to FR8200094A priority patent/FR2497510B1/fr
Priority to LU83869A priority patent/LU83869A1/fr
Priority to NL8200022A priority patent/NL8200022A/nl
Application granted granted Critical
Publication of IT1198434B publication Critical patent/IT1198434B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT47518/81A 1981-01-06 1981-01-06 Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina IT1198434B (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT47518/81A IT1198434B (it) 1981-01-06 1981-01-06 Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
US06/332,562 US4382092A (en) 1981-01-06 1981-12-21 Pharmaceutical composition comprising gamma-butyrobetaine for the treatment of syndromes induced by L-carnitine deficiency
IL64632A IL64632A0 (en) 1981-01-06 1981-12-24 Pharmaceutical composition comprising gamma-butyrobetaine for the treatment of syndromes induced by l-carnitine deficiency
BE0/206948A BE891639A (fr) 1981-01-06 1981-12-28 Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine
AU79087/81A AU548787B2 (en) 1981-01-06 1981-12-30 Gamma-butyrobetaine use in l-carnitine deficiency
IE3099/81A IE52404B1 (en) 1981-01-06 1981-12-31 Pharmaceutical composition comprising gamma-butyrobetaine for the treatment of syndromes induced by l-carnitine deficiency
DE19823200016 DE3200016A1 (de) 1981-01-06 1982-01-02 Oral oder parenteral berabreichbare arzneimittelzubereitung mit einem gehalt an (gamma)-butyrobetain zur behandlung von syndromen, hervorgerufen durch l-carnitinmangel
SE8200007A SE453569B (sv) 1981-01-06 1982-01-04 Gammabutyrobetain till anvendning for behandling av patienter som lider av l-karnitinbristsyndrom
GB8200054A GB2091101B (en) 1981-01-06 1982-01-04 Pharmaceutical composition comprising gammabutyro-betaine for the treatment of syndromes induced by l-carnitine deficiency
GR66937A GR75132B (it) 1981-01-06 1982-01-04
CH31/82A CH649218A5 (it) 1981-01-06 1982-01-05 Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina.
JP57000842A JPS57136516A (en) 1981-01-06 1982-01-05 Medicine for l-carnitine deficiency
FR8200094A FR2497510B1 (fr) 1981-01-06 1982-01-06 Composition pharmaceutique contenant de la g-butyrobetaine pour le traitement des syndromes provoques par une carence en l-carnitine
LU83869A LU83869A1 (fr) 1981-01-06 1982-01-06 Procede de preparation d'une composition pharmaceutique comprenant de la gamma-butyrobetaine pour le traitement de syndromes provoques par une deficience en l-carmitine
NL8200022A NL8200022A (nl) 1981-01-06 1982-01-06 Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47518/81A IT1198434B (it) 1981-01-06 1981-01-06 Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina

Publications (2)

Publication Number Publication Date
IT8147518A0 true IT8147518A0 (it) 1981-01-06
IT1198434B IT1198434B (it) 1988-12-21

Family

ID=11260827

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47518/81A IT1198434B (it) 1981-01-06 1981-01-06 Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina

Country Status (15)

Country Link
US (1) US4382092A (it)
JP (1) JPS57136516A (it)
AU (1) AU548787B2 (it)
BE (1) BE891639A (it)
CH (1) CH649218A5 (it)
DE (1) DE3200016A1 (it)
FR (1) FR2497510B1 (it)
GB (1) GB2091101B (it)
GR (1) GR75132B (it)
IE (1) IE52404B1 (it)
IL (1) IL64632A0 (it)
IT (1) IT1198434B (it)
LU (1) LU83869A1 (it)
NL (1) NL8200022A (it)
SE (1) SE453569B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US5030458A (en) * 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
IT1219448B (it) * 1988-02-12 1990-05-18 Sigma Tau Ind Farmaceuti Alimento per animali domestici carnivori, in particolare per cani integrato con l-carnitina
US5240961A (en) * 1992-07-02 1993-08-31 Shug Austin L Method of treating reduced insulin-like growth factor and bone loss associated with aging
US20030170290A1 (en) * 1993-06-16 2003-09-11 Shug Austin L. Delayed release carnitine
JP2553013B2 (ja) * 1993-07-19 1996-11-13 ヤマハ発動機株式会社 燃料噴射式エンジンの吸気装置
US5569457A (en) * 1994-11-18 1996-10-29 Shug; Austin L. Method of stimulating antibody formation
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
KR100411275B1 (ko) * 1999-09-15 2003-12-18 주식회사 포스코 언로더 코일 적치위치 제어장치
DE19956772A1 (de) * 1999-11-25 2001-06-07 Basf Ag Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
LV12979B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
NL8200022A (nl) 1982-08-02
GB2091101B (en) 1985-02-20
FR2497510B1 (fr) 1986-04-25
DE3200016C2 (it) 1992-12-03
IE52404B1 (en) 1987-10-14
GB2091101A (en) 1982-07-28
JPH0424325B2 (it) 1992-04-24
FR2497510A1 (fr) 1982-07-09
SE8200007L (sv) 1982-07-07
IE813099L (en) 1982-07-06
DE3200016A1 (de) 1982-08-12
GR75132B (it) 1984-07-13
CH649218A5 (it) 1985-05-15
JPS57136516A (en) 1982-08-23
SE453569B (sv) 1988-02-15
IL64632A0 (en) 1982-03-31
AU7908781A (en) 1982-07-15
IT1198434B (it) 1988-12-21
BE891639A (fr) 1982-04-16
AU548787B2 (en) 1986-01-02
US4382092A (en) 1983-05-03
LU83869A1 (fr) 1982-05-07

Similar Documents

Publication Publication Date Title
IT8147518A0 (it) Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
IT1149123B (it) Spazzolino da denti provvisto di mezzi per il massaggio gengivale
IT8247916A0 (it) Composizione rimineralizzante per applicazioni dentarie
PT73686A (pt) Pharmaceutical formulation
ZA828797B (en) Pharmaceutical formulation
DK345682A (da) Pharmaceutiske expienser
IT1162879B (it) Composizioni farmaceutiche
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
GB2075838B (en) Pharmaceutical composition containing l-carnitine or an l-acyl carnitine
IT8467840A1 (it) Composto e composizione farmaceutica per il trattamento della osteoporosi.
SE8300912L (sv) Kompositioner for behandling av glaukom
IT8248677A0 (it) Formulazioni farmaceutiche
DK227083D0 (da) Farmaceutisk komposition og fremgangsmade til dens fremstilling
IT1155504B (it) Posto di trattamento dentistico
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT1119854B (it) Composizione farmaceutica comprendente l-carnitina per il trattamento di disfunzioni cardiache
BE893812A (fr) Compositions pharmaceutiques comprenant un derive acyle de carnitine
GB2132085B (en) Pharmaceutical composition containing l-carnitine
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
IT1208432B (it) Composizioni farmaceutiche
IT8048854A0 (it) Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
ZA822176B (en) Pharmaceutical compositions for the treatment of diabetes
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
IT8168607A0 (it) Composizione farmaceutica per la terapia delle sindromi depressive
FI830597A0 (fi) Foer hudvaord avsedd farmaceutisk komposition

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19931202